Close Menu

NEW YORK (GenomeWeb) – Urological cancer diagnostics firm MDxHealth announced today that it expects to fall short of its previous guidance for 2017 revenue growth based on preliminary fourth quarter results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.